Opinion

Video

Acalabrutinib-Based Treatment Clinical Trial Updates

Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Related Content
Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be recommended: © stock.adobe.com
April 21st 2025

Pausing BTKi for Vaccine Did Not Boost Immunity in CLL

Spencer Feldman
Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be recommended, a trial found.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Illustration of Chester.
April 18th 2025

Daffodils and Determination from a Patient with Chronic Lymphocytic Leukemia

Chester Freeman
Each spring, I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.
CURE Talks Cancer podcast
December 31st 2020

The Treatment Journey of a Patient with CLL

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
Chester Freeman was diagnosed with bladder cancer and most recently with chronic lymphocytic leukemia (CLL). Read Chester's blogs here!
March 25th 2025

Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia

Chester Freeman
Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.
Illustration of blood cells.
March 14th 2025

Longer Imbruvica and Venclexta Treatment May Be Beneficial in R/R CLL

Alex Biese
For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found to be beneficial.